Showing 221 - 240 results of 916 for search '"type 2 diabetes mellitus"', query time: 0.12s Refine Results
  1. 221
  2. 222
  3. 223
  4. 224
  5. 225
  6. 226

    Association between Toll-Like Receptor 4 and Occurrence of Type 2 Diabetes Mellitus Susceptible to Pulmonary Tuberculosis in Northeast China by Yuze Li, Dianzhong Li, Jinfeng Zhang, Shurui Liu, Haijun Chen, Kun Wu

    Published 2016-01-01
    “…The purpose of this study is to explore why type 2 diabetes mellitus (T2DM) patients are susceptible to pulmonary tuberculosis through detection of serum Toll-like receptor 4 (TLR4), an important immune-related receptor, especially in terms of content and TLR4 gene polymorphism. …”
    Get full text
    Article
  7. 227

    Gypenoside ameliorates insulin resistance and hyperglycemia via the AMPK-mediated signaling pathways in the liver of type 2 diabetes mellitus mice by Mengxue Song, Dehong Tan, Bin Li, Yanqun Wang, Lin Shi

    Published 2022-09-01
    “…The effects of two Gps (Gp-I and Gp-II) on type 2 diabetic mellitus (T2DM) mice, induced by high-fat and high-sugar diet and streptozotocin, were evaluated to explore the mechanism of their hypoglycemic actions. …”
    Get full text
    Article
  8. 228
  9. 229

    Effects of a Novel Glucokinase Activator, HMS5552, on Glucose Metabolism in a Rat Model of Type 2 Diabetes Mellitus by Ping Wang, Huili Liu, Li Chen, Yingli Duan, Qunli Chen, Shoumin Xi

    Published 2017-01-01
    “…We investigated the possible effects of a novel glucokinase activator (GKA), HMS5552, to the GK in rats with type 2 diabetes mellitus (T2DM). Male Sprague-Dawley (SD) rats were divided into four groups: control group, diabetic group, low-dose (10 mg/kg) HMS5552-treated diabetic group (HMS-L), and high-dose (30 mg/kg) HMS5552-treated diabetic group (HMS-H). …”
    Get full text
    Article
  10. 230

    Meta-analysis of the clinical efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease by Yuan-Yuan Xu, Xu Wang, Yu-Qing She, Jie Liu, Qing Zhang

    Published 2024-09-01
    “…This study aimed to systematically evaluate the efficacy of liraglutide in treating type 2 diabetes mellitus (T2DM) complicated with non-alcoholic fatty liver disease (NAFLD) by comparing liraglutide with placebo or other drugs (mainly insulin). …”
    Get full text
    Article
  11. 231

    Effect of Modified Roux-en-Y Gastric Bypass Surgery on GLP-1, GIP in Patients with Type 2 Diabetes Mellitus by Shao-Wei Xiong, Jing Cao, Xian-Ming Liu, Xing-Ming Deng, Zeng Liu, Fang-Ting Zhang

    Published 2015-01-01
    “…The type 2 diabetes mellitus (T2DM) is one of the most serious diseases that threaten public health. …”
    Get full text
    Article
  12. 232

    The Age-Specific Association of Waist Circumference and Risk of Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus in Shandong, China by Lingling Xu, Weihong Yu, Ping Huang, Chunying Li, Yan Li, Meng Wang, Qun Xu, Jing Wang, Caixia Zheng, Bin Qu, Yanping Zhao, Meng Niu, Ou Wang, Fengying Gong

    Published 2015-01-01
    “…To examine the association of three most common obesity measures including body mass index (BMI), waist circumference (WC), and waist-to-hip ratio (WHR) with chronic kidney disease (CKD) risk in patients with type 2 diabetes mellitus (T2D). Design. Cross-sectional evaluation of the effect of anthropometric measures on CKD risk. …”
    Get full text
    Article
  13. 233

    Factors Associated with Utilization of Dipeptidyl-4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Retrospective Study by Hasniza Zaman Huri, NorFarahen Selamat, Shireene Ratna Vethakkan

    Published 2014-01-01
    “…This study aims to analyse the utilization patterns of DPP-4 inhibitors, factors that influenced the choice of agent, and the rationale for treatment with DPP-4 inhibitors in patients with type 2 diabetes mellitus. This retrospective study was conducted to address the utilization pattern of DPP-4 inhibitors and factors that influence choice in type 2 diabetes mellitus patients. 299 subjects taking either sitagliptin or vildagliptin from September 2008 to September 2012 were included in the study. …”
    Get full text
    Article
  14. 234

    Muscle quality index is correlated with insulin resistance and type 2 diabetes mellitus: a cross-sectional population-based study by Mengye Zhang, Hao Lin, Xue Xu

    Published 2025-02-01
    “…Current evidence on the correlation between MQI and type 2 diabetes mellitus (T2DM), insulin resistance (IR) is limited. …”
    Get full text
    Article
  15. 235
  16. 236

    Hemoglobin A1c to Detect Prediabetes or Type 2 Diabetes Mellitus in a Rural Population of Wardha District in India by Shilpa Gaidhane, Ranjit Sah, Quazi Syed Zahiruddin, Nazli Khatib, Shital Telrandhe, Sonali Choudhari, Abhay Gaidhane

    Published 2024-04-01
    “…Nearly half of type 2 diabetes mellitus (T2DM) cases go undiagnosed. This study assesses glycated hemoglobin A1c (HbA1c) for diagnosing T2DM and prediabetes in at-risk individuals. …”
    Get full text
    Article
  17. 237
  18. 238

    Differential risk of cardiovascular complications in patients with type-2 diabetes mellitus in Ghana: A hospital-based cross-sectional study. by Christian Obirikorang, Evans Asamoah Adu, Anthony Afum-Adjei Awuah, Samuel Nkansah Darko, Frank Naku Ghartey, Samuel Ametepe, Eric N Y Nyarko, Enoch Odame Anto, William Kwame Boakye Ansah Owiredu

    Published 2025-01-01
    “…<h4>Aim</h4>To characterize clinically relevant subgroups of patients with type-2 diabetes mellitus (T2DM) based on adiposity, insulin secretion, and resistance indices.…”
    Get full text
    Article
  19. 239

    The Association between Neutrophil-to-Lymphocyte Ratio and Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis by Tiruneh Adane, Mulugeta Melku, Yilkal Belete Worku, Alebachew Fasil, Melak Aynalem, Amanuel Kelem, Solomon Getawa

    Published 2023-01-01
    “…Glycated hemoglobin (HbA1c) is a commonly used clinical marker to monitor the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the ongoing inflammatory changes in the body. …”
    Get full text
    Article
  20. 240

    Medication following bariatric surgery for type 2 diabetes mellitus (BY-PLUS) study: rationale and design of a randomised controlled study by Alexander Dimitri Miras, Carel le Roux, Alexis Sudlow, Ricardo Vitor Cohen, Hassan Kahal, Dimitri J Pournaras, Jill Townley, Helen Heneghan

    Published 2022-07-01
    “…Introduction Bariatric surgery is an effective method of controlling glycaemia in patients with type 2 diabetes mellitus (T2DM) and obesity. Long-term studies suggest that although glycaemic control remains good, only 20%–40% of patients will maintain remission according to the American Diabetes Association criteria.Purpose This trial aims to examine the safety and efficacy of combining Roux-en-Y gastric bypass or sleeve gastrectomy with goal-directed medical therapy to improve long-term glycaemic control of T2DM.Methods and analysis This prospective, open-label multicentre randomised controlled trial (RCT) will recruit 150 patients with obesity and T2DM from tertiary care obesity centres. …”
    Get full text
    Article